[A prospective analysis of coercive measures in an inpatient department of child and adolescent psychiatry].
So far the discussion of coercive measures in the work with children and adolescents relies more on individual experiences than on empirical data. In the department of child and adolescent psychiatry "Die Weissenau" all coercive measures in the past six years have been evaluated prospectively. 178 patients (9.2 %) of 1939 patients totally admitted between 1999 and 2004 received coercive measures. For each measure there was a documentation of personal data, reason and duration of the coercive measure. The proportion of patients affected by coercive measures in this department was lower compared to other studies. Female patients were more often subject to coercive measures. Mostly coercive measures were used in the means of protection against self-directed aggressive behaviour. The average duration of coercive measures has been reduced after the implementation of a stringent documentation system and ensuing discussions of the topic. It can be concluded that a stringent documentation, an evaluation and reflection of coercive measures can help to assume quality in the process of coercive measures.
Fetzer
Anette E
AE
Klinik für Kinder- und Jugendpsychiatrie und Psychotherapy, Zentrum für Psychiatrie Weissenau, Ravensburg. anette.fetzer@zfp-zentrum.de
Steinert
Tilman
T
Metzger
Wolfram
W
Fegert
Jörg M
JM
D000293:Adolescent; D000374:Aggression / Q000523:psychology; D002648:Child; D003068:Coercion; D003430:Cross-Sectional Studies; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D010356:Patient Isolation / Q000523:psychology / Q000706:statistics & numerical data; D011446:Prospective Studies; D011567:Psychiatric Department, Hospital / Q000706:statistics & numerical data*; D011619:Psychotropic Drugs / Q000008:administration & dosage; D012149:Restraint, Physical / Q000523:psychology / Q000706:statistics & numerical data; D012307:Risk Factors
D011619:Psychotropic Drugs